Skip to content

Evaluation of Efficacy and Safety of General Anesthesia Using Dexmedetomidine With Sevoflurane in Patients Undergoing Arthroscopic Shoulder Surgery: Preliminary Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01687868
Enrollment
19
Registered
2012-09-19
Start date
2012-07-31
Completion date
2013-05-31
Last updated
2014-03-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arthroscopic Shoulder Surgery in the Beach-chair Position

Brief summary

Patients undergoing shoulder arthroscopy in the beach chair position may be at risk for adverse neurologic events due to cerebral ischemia. Dexmedetomidine, a potent alpha adrenoceptor agonist which dose-dependently reduces arterial blood pressure and heart rate, decreases the hemodynamic and catecholamine response in the perioperative period. dexmedetomidine has an effect of peripheral vasoconstriction thus it is theologically appropriate for reducing bleeding for arthroscopic operation field. The aim of this study is to evaluate the efficacy and the safety of dexmedetomidine on cerebral oxygen saturation, cognitive function, hemodynamic stability and operative field in patients undergoing arthroscopic shoulder surgery in the beach-chair position.

Interventions

DRUGDexmedetomidine

dexmedetomidine 0.7mcg/kg/hr continuous infusion

Sponsors

Yonsei University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* ASA I-II * Aged between 20 and 70 year * general anesthesia for arthroscopic shoulder surgery in the beach-chair position

Exclusion criteria

* Congestive heart failure, coronary artery occlusive disease * Bradycardia \< 50 BPM, 2nd degree \< AV block * Poorly controlled hypertension * ß blocker medication * Coagulopathy * Pregnancy, nursing

Design outcomes

Primary

MeasureTime frameDescription
Regional cerebral oxygen saturation valueT1,T2,T3, T4, T5,T6, T7, T8, T9 time of post-dose during surgeryBefore the anesthetic induction(T1), Before endotracheal intubation(T2), After endotracheal intubation(T3), Before the beach-chair position(T4), 5 minutes after the beach-chair position(T5), Before the operation(T6), 5 minutes after the incision(T7), After removal of the arthroscopy(T8), at the end of the operation(T9)

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026